Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lafreniere

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Surgical Oncology|April 1, 1990
Bloody nipple discharge during pregnancy: a rationale for conservative treatmentR Lafreniere
Surgery, Gynecology & Obstetrics|December 1, 1991
A new skin hook retainer as an aid to skin flap retractionR Lafreniere
Journal of Surgical Oncology|August 1, 1991
Indwelling subclavian catheters and a visit with the "pinched-off sign"R Lafreniere
Cancer Research|August 1, 1985
Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2R Lafreniere, S A Rosenberg
Endocrinology|November 1, 1970
Induction of uterine phosphofructokinase by cyclic 3',5'-adenosine monophosphateR L Singhal, R Lafreniere
Gastroenterology|April 1, 1988
Interleukin-1 and interleukin-2 in chronic type B hepatitisG Y Minuk, R LaFreniere
Journal of the National Cancer Institute|February 1, 1986
A novel approach to the generation and identification of experimental hepatic metastases in a murine modelR Lafreniere, S A Rosenberg
Surgery, Gynecology & Obstetrics|January 1, 1986
The use of the skin stapler for drape fixation during operationsR Lafreniere, A S Ketcham
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinomaR Lafreniere, S A Rosenberg
Journal of Surgical Oncology|May 1, 1985
Hartmann's pouch carcinomaR Lafreniere, A S Ketcham
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Surgical Oncology|April 1, 1990
Bloody nipple discharge during pregnancy: a rationale for conservative treatmentR Lafreniere
Surgery, Gynecology & Obstetrics|December 1, 1991
A new skin hook retainer as an aid to skin flap retractionR Lafreniere
Journal of Surgical Oncology|August 1, 1991
Indwelling subclavian catheters and a visit with the "pinched-off sign"R Lafreniere
Cancer Research|August 1, 1985
Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2R Lafreniere, S A Rosenberg
Endocrinology|November 1, 1970
Induction of uterine phosphofructokinase by cyclic 3',5'-adenosine monophosphateR L Singhal, R Lafreniere
Gastroenterology|April 1, 1988
Interleukin-1 and interleukin-2 in chronic type B hepatitisG Y Minuk, R LaFreniere
Journal of the National Cancer Institute|February 1, 1986
A novel approach to the generation and identification of experimental hepatic metastases in a murine modelR Lafreniere, S A Rosenberg
Surgery, Gynecology & Obstetrics|January 1, 1986
The use of the skin stapler for drape fixation during operationsR Lafreniere, A S Ketcham
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinomaR Lafreniere, S A Rosenberg
Journal of Surgical Oncology|May 1, 1985
Hartmann's pouch carcinomaR Lafreniere, A S Ketcham
Pageof 5